In addition to being common between the two screens, CD93-ALDH18A1 in pancreatic, KEAP1-ATP1A1 in lung, BRAF-MAPK1, BRAF-MDM2, and BRAF-CDK5 in skin, RHOA-CTNNB1 in stomach, and OR6C1-MDM2 in large-intestine cancers also found support in the PRISM dataset (significance level α = 0.1) before multiple testing correction (Supplementary Data 3). This evidence concerns the gene ATP1A1 and colorectal cancer.